Cardio Diagnostics Holdings is trading 7.81% up at $2.07, with the move appearing primarily aligned with stronger risk appetite as broader markets rally.
- It closed September 21, 2026, at $1.92; no new company-specific announcement was found that day.
- Shareholders’ September 18 approval of financing flexibility remains the latest material update, including potential issuance exceeding 20% of common stock.
- The Nasdaq Composite gained 2.42%, while the S&P 500 rose 1.54%.